The COVIVAC COVID-19 vaccine is produced by the Institute of Vaccines
and Medical Biologicals (IVAC) (Source: Ministry of Health)
Speaking at a meeting of the special working group on COVID-19
vaccine development and clinical trials on July 17, Thuan said COVID-19 vaccine
is a matter of paramount concern to the Vietnamese Party and State leaders.
Prime Minister Pham Minh Chinh, has asked World Health Organisation (WHO)
experts to help Vietnam with COVID-19 vaccine research and production to ensure
vaccine self-supply.
This would help the research and clinical trials of Nanocovax and COVIVAC
vaccines, two candidates making the most progress in the four under development
in Vietnam, he said.
Thuan emphasised that the issue is how to make full use of the support from WHO
experts in the accreditation of laboratories, the recognition of clinical trial
procedures and most importantly the recognition of Vietnam’s own COVID-19
vaccine towards vaccine self-sufficiency, and furthermore, vaccine exports.
The health official also suggested that members of the Special Working Group
work to their best capacity in providing “maximum support to domestic
researchers and manufacturers of COVID-19 vaccines,” with most flexible and best
possible assistance to the ones in need of support.
The National Institute for Hygiene and Epidemiology in Hanoi and HCM City
Pasteur Institute, two focal points in organising vaccine clinical trials, were
asked to proactively prepare the necessary conditions both in terms of human
resources, equipment and facilities, etc. to carry out necessary components in
trials of transferred vaccines.
The Ministry of Health will soon submit to the Government a plan to use the
budget from the National COVID-19 Vaccine Fund to support the implementation of
phase 3 clinical trials for domestically developed vaccines as well as
transferred vaccines, and request the Government to direct relevant ministries
and agencies to coordinate with the health ministry in participating in clinical
trial studies to ensure safety, progress and efficiency.
Thuan asked that members join a Viber group, which will also include the
contacts of health ministry’s leaders, to have timely exchanges on matters
concerning vaccine research and development.
“Science matters the most in the research and development of domestic COVID-19
vaccines, but flexibility will also be an important issue to consider. We strive
to have at least one manufacturer making a successful homegrown COVID-19 vaccine
by the end of 2021 at the earliest,” the health official stressed.
Nanogen, the developer of the Nano Covax vaccine, this week said it has
administered the first jab to 13,000 volunteers in its phase 3 human trials,
with the second dose expected to be given before end of August, eyeing full
clinical data for reviews this year.
The Covivac vaccine, by the Institution of Vaccine and Biological Medical in Nha
Trang city, wrapped up phase 1 in late June and plans to carry out phase 2 soon.
Source: VNA